OBSERVE MEDICAL ASA financials
OBSERVE MEDICAL ASA
9845005F38B74FFJ1B65 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | NOK 27.9M | NOK 19.5M |
| Gross profit | NOK 9.3M | NOK 5.2M |
| Operating expenses | NOK 47.0M | NOK 53.4M |
| Employee benefits expense | NOK 26.0M | NOK 28.5M |
| Raw materials & consumables used | NOK 18.7M | NOK 14.3M |
| Depreciation & amortisation | NOK 13.6M | NOK 10.9M |
| Operating profit (EBIT) | -NOK 51.3M | -NOK 59.1M |
| Net finance income / (cost) | -NOK 9.1M | NOK 8.4M |
| Finance costs | NOK 16.6M | NOK 10.7M |
| Profit before tax | -NOK 60.3M | -NOK 50.7M |
| Income tax expense | NOK 17.0K | NOK 76.0K |
| Profit for the year | -NOK 60.4M | -NOK 50.8M |
| — attributable to owners | -NOK 60.4M | -NOK 50.8M |
| Total comprehensive income | -NOK 53.1M | -NOK 53.3M |
| Per share | ||
| Basic EPS | NOK -1.05 | NOK -1.08 |
| Diluted EPS | NOK -1.05 | NOK -1.08 |
| Cash flow statement | ||
| Net cash from operating activities | -NOK 24.5M | -NOK 51.3M |
| Net cash from investing activities | -NOK 7.6M | -NOK 58.4M |
| Net cash from financing activities | NOK 31.7M | NOK 120.9M |
| Lease liability payments | NOK 1.6M | NOK 1.4M |
| Balance sheet | ||
| Total assets | NOK 253.5M | NOK 215.8M |
| Non-current assets | NOK 226.3M | NOK 186.9M |
| Property, plant & equipment | NOK 2.0M | NOK 4.2M |
| Intangible assets & goodwill | NOK 102.3M | NOK 100.0M |
| Current assets | NOK 27.2M | NOK 28.9M |
| Inventories | NOK 6.9M | NOK 8.1M |
| Trade & other receivables | NOK 3.1M | NOK 4.7M |
| Cash & equivalents | NOK 13.7M | NOK 13.6M |
| Total equity | NOK 115.6M | NOK 138.3M |
| Non-current liabilities | NOK 77.0M | NOK 5.3M |
| Long-term borrowings | NOK 50.0M | NOK 946.0K |
| Current liabilities | NOK 60.9M | NOK 72.2M |
| Short-term borrowings | NOK 4.5M | NOK 44.8M |
| Derived metrics | ||
| Operating margin | -183.5% | -303.0% |
| Net margin | -216.0% | -260.2% |
| Return on equity | -52.2% | -36.7% |
| Cash conversion ratio | 0.41× | 1.01× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | NOK 1.2M | -NOK 294.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | NOK 515.0K | -NOK 1.9M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | NOK 13.6M | NOK 10.9M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | NOK 0 | NOK 320.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | NOK 13.2M | -NOK 2.2M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | NOK 0 | -NOK 13.9M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | NOK 0 | NOK 54.0M |
| Comprehensive Income Attributable To Owners of Parent | -NOK 53.1M | -NOK 53.3M |
| Contingent Consideration Recognised As of Acquisition Date | NOK 1.6M | NOK 3.4M |
| Current Payables On Social Security and Taxes Other Than Income Tax | NOK 10.6M | NOK 6.1M |
| Current Tax Liabilities Current | NOK 0 | NOK 51.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | NOK 377.0K | -NOK 460.0K |
| Equity and Liabilities | NOK 253.5M | NOK 215.8M |
| Finance Income | NOK 7.5M | NOK 19.1M |
| Income Taxes Paid Refund Classified As Operating Activities | -NOK 36.0K | NOK 142.0K |
| Increase Decrease In Cash and Cash Equivalents | NOK 36.0K | NOK 10.8M |
| Increase Decrease Through Exercise of Options | NOK 478.0K | NOK 287.0K |
| Intangible Assets Other Than Goodwill | NOK 122.0M | NOK 82.8M |
| Issue of Equity | NOK 29.9M | NOK 205.4M |
| Issued Capital | NOK 49.6M | NOK 13.9M |
| Liabilities | NOK 137.9M | NOK 77.5M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | NOK 7.2M | -NOK 2.5M |
| Other Current Liabilities | NOK 28.0M | NOK 12.7M |
| Other Expense By Nature | NOK 21.0M | NOK 24.9M |
| Other Noncurrent Assets | NOK 32.0K | NOK 0 |
| Other Noncurrent Liabilities | NOK 25.5M | NOK 965.0K |
| Other Reserves | NOK 66.0M | NOK 124.4M |
| Proceeds From Issuing Shares | NOK 28.5M | NOK 155.6M |
| Trade and Other Current Payables To Trade Suppliers | NOK 17.8M | NOK 8.6M |
Every line item above is a fact tagged in OBSERVE MEDICAL ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.